Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Eduardo Perna"'
Autor:
Juan Esteban Gomez-Mesa, Stephania Galindo, Manuela Escalante-Forero, Yorlany Rodas, Andrea Valencia, Eduardo Perna, Alexander Romero, Iván Mendoza, Fernando Wyss, José Luis Barisani, Mario Speranza, Walter Alarco, Noel Alberto Flórez
Publikováno v:
Global Heart, Vol 18, Iss 1, Pp 60-60 (2023)
Background: Socioeconomic factors contribute to a more severe impact of COVID-19 in Latin American and Caribbean (LA&C) countries than in developed countries. Patients with a severe or critical illness can develop respiratory and cardiovascular compl
Externí odkaz:
https://doaj.org/article/ae5ba2cb1a6940b09565ba88608dff12
Publikováno v:
European Cardiology Review, Vol 14, Iss 2, Pp 82-88 (2019)
Chagas disease, originally a South American endemic health problem, is expanding worldwide because of people migration. Its main impact is on the cardiovascular system, producing myocardial damage that frequently results in heart failure. Pathogenic
Externí odkaz:
https://doaj.org/article/3c4cca618885462184b4cb15bef4ff6b
Autor:
Jorge Thierer, Eduardo Perna, Javier Marino, María Lorena Coronel, José Luis Barisani, Daniela García Brasca, Paula Pérez Terns, Juan Pablo Cimbaro Canella, Stella Maris Pereiro González
Publikováno v:
Revista Argentina de Cardiologia. 90:15-24
Introducción: Diferentes registros argentinos de insuficiencia cardíaca crónica (ICC) fueron generados en los últimos 25 años, en forma individual por la Sociedad Argentina de Cardiología (SAC) y la Federación Argentina de Cardiología (FAC),
Autor:
Yanina Castillo Costa, Flavio Delfino, Víctor Mauro, Heraldo D'Imperio, Carlos Barrero, Adrián Charask, Rodrigo Zoni, Stella Macín, Eduardo Perna, Juan Gagliardi
Publikováno v:
Current problems in cardiology. 48(2)
Cardiogenic Shock is one of the main causes of death in ST segment Elevation Myocardial Infarction. To know the clinical characteristics, in-hospital evolution and mortality of patients with Cardiogenic Shock. Patients enrolled in the ARGEN-IAM-ST Re
Autor:
Alejandro Hershson, Eduardo Perna
Publikováno v:
Revista Argentina de Cardiologia. 89:50-51
Autor:
Hershson, Alejandro, Eduardo Perna
Publikováno v:
Web of Science
Autor:
Eduardo Perna, Jorge Thierer
Publikováno v:
Revista Argentina de Cardiología. 81:515-529
Autor:
Eduardo Perna, Jorge Thierer
Publikováno v:
Revista Argentina de Cardiología. 81:484-496
Autor:
Aleksandr Svistov, Andrzej Rynkiewicz, Ján Kmec, Lars Kober, Perepech Nikita, Gordon Murray, Oleksii Korzh, Jacek Kubica, Joao Freitas, Jaromir Hradec, Eduardo Perna, Elena Golukhova, Jan Cornel, Antonis Manolis, Olga Moiseeva, Jean-Claude Barthelemy, Christopher Weir, Marianna Janion, Crina Julieta Sinescu, Catalina Arsenescu Georgescu, Michel GALINIER, Sergey Yakushin, Nestor Seredyuk, Philippe Gabriel STEG, Margus Viigimaa, Vladimir Zadionchenko, Ben Freedman, Daniel Pella, Felix Perez-Villa, Sergey Nedogoda, Roberto Ferrari, Yuri Lopatin, Vyacheslav Yurievich Mareev, Thomas Marwick, Yuriy Mostovoy, Viktor Tashchuk, Naida Bulaeva, Piotr Ponikowski, Oleg Zharinov, Andriy Bazylevych, Evgeny Zhilyaev, James Cameron, Andrejs Erglis, Tetyana KHOMAZYUK, Dmitry Zateyshchikov, John Atherton, Yury Vasyuk, Giedrius Varoneckas, David Kaye, Jan F Vojacek, Iurii Rudyk, DİLEK URAL, Sergiy Kolomiets
Publikováno v:
Lancet, 372(9641), 807-816. Elsevier Limited
Summary Background Ivabradine specifically inhibits the I f current in the sinoatrial node to lower heart rate, without affecting other aspects of cardiac function. We aimed to test whether lowering the heart rate with ivabradine reduces cardiovascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a8d0c627d3c094339baa9c43a712dd7
Autor:
Eduardo Perna
Publikováno v:
Journal of Cardiac Failure. 11:S186